VRK2 promoted the growth, sphere formation and subcutaneous tumorigenesis of pancreatic carcinoma cells as well as the organoid growth derived from the pancreatic cancer mouse model. This evidence concerns the gene VRK2 and exocrine pancreatic carcinoma.